eBay Inc vs Illumina, Inc. — how do they compare? eBay Inc trades at $111.7 (market cap $47.88B), while Illumina, Inc. trades at $264.24 (market cap $40.43B). The key difference: eBay Inc is the larger of the two by market cap, and eBay Inc pays a 1.15% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Illumina, Inc. for 83 Days on average.
| EBAY | ILMN | |
|---|---|---|
Market Cap | $47.88B | $40.43B |
Volume | 2,781,198 | 2,948,626 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $293.69 |
52-Week Low | $79.41 | $91.00 |
Typical Hold Time | 134 Days | 83 Days |
Enterprise Value | $51.71B | $41.79B |
Dividend Yield | 1.15% | — |
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $111.98, up 4.6% with bullish technical signals and strong earnings momentum after beating Q2 2026 estimates. The company maintains robust profitability with 72% gross margins and 47% ROE, while analyst consensus targets $117.68. Recent news highlights strategic focus on collectibles and live commerce growth, though GameStop's acquisition interest and executive selling warrant monitoring.
EBAY presents a balanced investment case with solid fundamentals and positive technicals, but faces competitive pressures from Amazon's multi-platform tools and potential acquisition uncertainty. The stock offers moderate upside to consensus targets with execution-dependent growth in key verticals.
Illumina (ILMN) trades at $264.40, down 3.34% on the day but up significantly year-to-date with strong technical momentum. The stock shows bullish moving average signals and trades near pivot point resistance at $268. Fundamentally, the company has delivered three consecutive quarterly earnings beats and returned to profitability in 2025 with $850 million net income after previous losses. Recent catalysts include S&P 500 inclusion effective September 21, 2026, and growing AI integration in genomics applications.
The outlook remains positive with analyst consensus favoring Buy ratings (54%) and a $241 price target, though current price exceeds consensus. Key opportunities include sequencing growth and AI-driven biological data expansion, while risks involve China market headwinds and elevated valuation multiples. Earnings growth and S&P 500 inclusion provide near-term catalysts, but the stock trades at premium valuations with P/E of 49.96 requiring sustained execution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →